![[GUIDE BAR]](../gif/cdguide.gif)
CELLULAR FUNCTION OF CD9  
DISEASE RELEVANCE OF CD9 AND FUNCTION OF CD9 IN INTACT ANIMAL  
MOLECULAR STRUCTURE OF CD9  
| CELL TYPE | MW UNREDUCED | MW REDUCED | Comment |
|---|---|---|---|
| All | 24 kDa (major band), 26 kDa (minor band) | Differentiating B cells (Yashukawa et al. 1988;Zola et al. 1991, 1989)** |
POST-TRANSCRIPTIONAL MODIFICATION OF CD9   - No information
POST-TRANSLATIONAL MODIFICATION OF CD9  
| MOLECULE | COMMENT |
|---|---|
| SP1 | SP1 has been shown to bind to the CD9 promoter |
SUBSTRATES FOR CD9   - No information
ENZYMES WHICH MODIFY CD9   - No information
LIGANDS FOR CD9 AND MOLECULES ASSOCIATED WITH CD9  
| MOLECULE | COMMENT |
|---|---|
| CD63 | CD9 associates with other members of the tetraspan superfamily (CD63, CD81, CD82) |
| CD81 | CD9 associates with other members of the tetraspan superfamily (CD63, CD81, CD82) |
| CD82 | CD9 associates with other members of the tetraspan superfamily (CD63, CD81, CD82) |
| Beta-1 integrins | In various cell line |
| CD41/CD61 (gpIIb/IIIa) | Associates with CD9 in platelets (Slupsky et al. 1989)** |
| HLA-DR | In pre-B cells and transfected B cell lines |
| HB-EGF (heparin-binding EGF) | CD9 is also associated with the transmembrane precursor form of a growth factor, HB-EGF (heparin-binding EGF) |
| PI4 kinase | CD9 is associated with PI4 kinase (Martin Hemler-personal communication)** |
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| MEM-192 | V Horejsi, Prague | |
| MEM-61 | V Horejsi, Prague | |
| SN4 | BK Seon, Buffalo | |
| SN4d | B K Seon, Buffalo |
SELECTION OF OTHER CD9-SPECIFIC REFERENCE MAB  
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| ALB-6 | Boucheix, Villejuif, France | |
| BA-2 | Kersey and LeBien, Minneapolis, MN | |
| 50H19 | Shaw, Edmonton, Canada | |
| mab7 | Jennings, Memphis TN |
REVIEWS
1. Rubinstein E,Boucheix C,Worthington RE,Carroll RC Anti-platelet antibody interactions with Fc gamma receptor. Semin Thromb Hemost 1995 21:10 PubMed
2. Wright MD,Tomlinson MG The ins and outs of the transmembrane 4 superfamily. Immunol Today 1994 15:588 PubMed
PRIMARY CITATIONS
3. Berditchevski F,Zutter MM,Hemler ME Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 1996 7:193 PubMed
4. Boucheix C,Benoit P,Frachet P,Billard M,Worthington RE,Gagnon J,Uzan G Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 1991 266:117 PubMed
5. Ikeyama S,Koyama M,Yamaoko M,Sasada R,Miyake M Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993 177:1231 PubMed
6. Iwamoto R,Higashiyama S,Mitamura T,Taniguchi N,Klagsbrun M,Mekada E Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 1994 13:2322 PubMed
7. Lanza F,Wolf D,Fox CF,Kieffer N,Seyer JM,Fried VA,Coughlin SR,Phillips DR,Jennings LK cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins. J Biol Chem 1991 266:10638 PubMed
8. Le Naour F,Prenant M,Francastel C,Rubinstein E,Uzan G,Boucheix C Transcriptional regulation of the human CD9 gene: characterization of the 5'-flanking region. Oncogene 1996 13:481 PubMed
9. Loffler S,Lottspeich F,Lanza F,Azorsa DO,ter Meulen V,Schneider-Schaulies J CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol 1997 71:42 PubMed
10. Oritani K,Wu X,Medina K,Hudson J,Miyake K,Gimble JM,Burstein SA,Kincade PW Antibody ligation of CD9 modifies production of myeloid cells in long- term cultures. Blood 1996 87:2252 PubMed
11. Rubinstein E,Le Naour F,Billard M,Prenant M,Boucheix C CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol 1994 24:3005 PubMed
12. Rubinstein E,Le Naour F,Lagaudriere-Gesbert C,Billard M,Conjeaud H,Boucheix C CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996 26:2657 PubMed
13. Seehafer JG,Tang SC,Slupsky JR,Shaw AR The functional glycoprotein CD9 is variably acylated: localization of the variably acylated region to a membrane-associated peptide containing the binding site for the agonistic monoclonal antibody 50H.19. Biochim Biophys Acta 1988 957:399 PubMed
14. Shaw AR,Domanska A,Mak A,Gilchrist A,Dobler K,Visser L,Poppema S,Fliegel L,Letarte M,Willett BJ Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem 1995 270:24092 PubMed
15. Tai XG,Yashiro Y,Abe R,Toyooka K,Wood CR,Morris J,Long A,Ono S,Kobayashi M,Hamaoka T,Neben S,Fujiwara H A role for CD9 molecules in T cell activation. J Exp Med 1996 184:753 PubMed
16. Willett BJ,Hosie MJ,Jarrett O,Neil JC Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 1994 81:228 PubMed
Portions copyright by Garland Press and by the International Workshops on Human Leukocyte Differentiation Antigens; used with permission
Modified 10/14/99 mpr@mail.nih.gov